Trexquant Investment’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.76M | Sell |
320,349
-3,579
| -1% | -$67.7K | 0.03% | 684 |
|
|
2026
Q1 | $7.05M | Buy |
323,928
+145,585
| +82% | +$2.82M | 0.05% | 510 |
|
|
2025
Q4 | $3.84M | Buy |
178,343
+17,681
| +11% | +$373K | 0.03% | 713 |
|
|
2025
Q3 | $3.1M | Sell |
160,662
-226,835
| -59% | -$4.04M | 0.03% | 730 |
|
|
2025
Q2 | $6.63M | Buy |
387,497
+199,513
| +106% | +$8.51M | 0.07% | 417 |
|
|
2025
Q1 | $12M | Buy |
+187,984
| New | +$19.8M | 0.14% | 193 |
|
|
2024
Q3 | – | Sell |
-39,950
| Closed | -$6.31M | – | 1842 |
|
|
2024
Q2 | $6.31M | Buy |
39,950
+27,101
| +211% | +$3.48M | 0.1% | 333 |
|
|
2024
Q1 | $1.66M | Sell |
12,849
-54,584
| -81% | -$6.69M | 0.03% | 719 |
|
|
2023
Q4 | $6.5M | Buy |
+67,433
| New | +$6.47M | 0.15% | 178 |
|
|
2023
Q1 | – | Sell |
-23,579
| Closed | -$3.06M | – | 1751 |
|
|
2022
Q4 | $3.06M | Buy |
23,579
+639
| +3% | +$74K | 0.09% | 303 |
|
|
2022
Q3 | $2.54M | Buy |
22,940
+4,974
| +28% | +$501K | 0.09% | 293 |
|
|
2022
Q2 | $1.35M | Sell |
17,966
-23,616
| -57% | -$1.74M | 0.06% | 392 |
|
|
2022
Q1 | $3.25M | Buy |
41,582
+24,011
| +137% | +$1.84M | 0.15% | 167 |
|
|
2021
Q4 | $1.58M | Buy |
+17,571
| New | +$1.5M | 0.1% | 264 |
|
|
2021
Q2 | – | Sell |
-13,885
| Closed | -$1.03M | – | 1482 |
|
|
2021
Q1 | $1.03M | Buy |
13,885
+9,779
| +238% | +$902K | 0.09% | 271 |
|
|
2020
Q4 | $700K | Sell |
4,106
-4,036
| -50% | -$598K | 0.07% | 350 |
|
|
2020
Q3 | $1.14M | Sell |
8,142
-3,132
| -28% | -$476K | 0.07% | 372 |
|
|
2020
Q2 | $1.81M | Buy |
+11,274
| New | +$1.53M | 0.13% | 222 |
|
|
2020
Q1 | – | Sell |
-21,118
| Closed | -$2.73M | – | 1396 |
|
|
2019
Q4 | $2.73M | Buy |
21,118
+930
| +5% | +$93.9K | 0.16% | 187 |
|
|
2019
Q3 | $1.52M | Buy |
+20,188
| New | +$2.38M | 0.13% | 211 |
|
|
2019
Q2 | – | Sell |
-3,377
| Closed | -$403K | – | 1099 |
|
|
2019
Q1 | $403K | Buy |
+3,377
| New | +$434K | 0.03% | 648 |
|
|
2018
Q3 | – | Sell |
-4,274
| Closed | -$565K | – | 1176 |
|
|
2018
Q2 | $565K | Sell |
4,274
-2,861
| -40% | -$270K | 0.04% | 502 |
|
|
2018
Q1 | $529K | Buy |
+7,135
| New | +$476K | 0.04% | 613 |
|
|
2017
Q4 | – | Sell |
-8,846
| Closed | -$401K | – | 1243 |
|
|
2017
Q3 | $401K | Buy |
+8,846
| New | +$354K | 0.1% | 352 |
|
|
2016
Q4 | – | Sell |
-18,700
| Closed | -$1.15M | – | 1122 |
|
|
2016
Q3 | $1.15M | Buy |
+18,700
| New | +$565K | 0.26% | 109 |
|
|
2015
Q2 | – | Sell |
-27,991
| Closed | -$371K | – | 1223 |
|
|
2015
Q1 | $371K | Buy |
27,991
+10,991
| +65% | +$146K | 0.04% | 787 |
|
|
2014
Q4 | $245K | Buy |
+17,000
| New | +$288K | 0.04% | 762 |
|
Other funds holding SRPT
EAM
Trexquant Investment's SRPT Position: Q2 2026 in Review
Trexquant Investment reduced its Sarepta Therapeutics (SRPT) stake by 1.1% in Q2 2026, selling an estimated $67.7K and leaving 320,349 shares worth $5.76M. The position accounts for 0.03% of the portfolio, ranked #684.
Trexquant Investment first reported a position in SRPT in Q4 2014 and has held it in 27 quarters since. The position peaked at $12M in Q1 2025. 324 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.
- Trexquant Investment held 320,349 shares of Sarepta Therapeutics worth $5.76M as of Q2 2026.
- Trexquant Investment sold 3,579 Sarepta Therapeutics shares in Q2 2026, an estimated $67.7K.
- Sarepta Therapeutics made up 0.03% of Trexquant Investment's portfolio in Q2 2026, its #684 holding.
- Trexquant Investment first reported a position in Sarepta Therapeutics in Q4 2014 and has held it in 27 quarters since.
- Trexquant Investment's Sarepta Therapeutics position peaked at $12M in Q1 2025.
- 324 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.
Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.